As part of the patent linkage scheme in Singapore, applicants for registration of a therapeutic product in Singapore must declare whether there is a patent in force in respect of the therapeutic product. Whilst there was previously some uncertainty as to whether a process patent can be a patent "in respect of the therapeutic product", the Court of Appeal in Zyfas Medical Co v Millennium Pharmaceuticals, Inc.  SGCA 84 has now confirmed that it can.
Hence, applicants for therapeutic product registration in Singapore should consider the need to declare, not only the product patent for the active ingredient in the therapeutic product, but also process patents.
In this interactive live webinar, we will discuss this and other aspects of recent decisions of the Singapore courts in relation to the declarations to be made when applying for therapeutic product registration in Singapore, and the practical impact of these decisions.
The webinar has ended.
If you would like to subscribe to our Singapore events, please let us know here.